Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lanjin (蓝金) is a prominent brand of pharmaceutical products developed and marketed by Hunan Zhongjia Pharmaceutical Development Co., Ltd., primarily targeting the common cold and respiratory infections. The brand encompasses a variety of formulations, including both Traditional Chinese Medicine (TCM) and western-style combination drugs. The most notable product under the Lanjin brand for 'wind-heat' syndrome is the **Lanjin Yinqiao Jiedu Tablet**, a classic TCM formula containing ingredients like Honeysuckle and Forsythia, which is used to alleviate fever, headache, and sore throat. Other significant products include **Lanjin Compound Paracetamol and Amantadine Hydrochloride Capsules** (a western medicine combination for general cold symptoms) and **Lanjin Xiao'er Kechuan Ling Keli** (a pediatric formulation for cough and asthma). These medications are widely utilized in China for the treatment of acute upper respiratory tract infections and associated syndromes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lanjin.